Crystal Structures of Human PAICS Reveal Substrate and Product Binding of an Emerging Cancer Target

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2020 Jun 24

PMID 32571877

Citations 7

Authors

Jana Skerlova

Judith Unterlass

Mona Gottmann

Petra Marttila

Evert Homan

Thomas Helleday

Ann-Sofie Jemth

Pal Stenmark

Affiliations

Soon will be listed here.

Abstract

The bifunctional human enzyme phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthetase (PAICS) catalyzes two essential steps in the purine biosynthesis pathway. PAICS is overexpressed in many cancers and could be a promising target for the development of cancer therapeutics. Here, using gene knockdowns and clonogenic survival and cell viability assays, we demonstrate that PAICS is required for growth and survival of prostate cancer cells. PAICS catalyzes the carboxylation of aminoimidazole ribonucleotide (AIR) and the subsequent conversion of carboxyaminoimidazole ribonucleotide (CAIR) and l-aspartate to -succinylcarboxamide-5-aminoimidazole ribonucleotide (SAICAR). Of note, we present the first structures of human octameric PAICS in complexes with native ligands. In particular, we report the structure of PAICS with CAIR bound in the active sites of both domains and SAICAR bound in one of the SAICAR synthetase domains. Moreover, we report the PAICS structure with SAICAR and an ATP analog occupying the SAICAR synthetase active site. These structures provide insight into substrate and product binding and the architecture of the active sites, disclosing important structural information for rational design of PAICS inhibitors as potential anticancer drugs.

Citing Articles

Genome-scale CRISPR-Cas9 screen identifies as a therapeutic target for wild-type non-small cell lung cancer.

Li Y, Zhu L, Mao J, Zheng H, Hu Z, Yang S MedComm (2020). 2024; 5(3):e483.

PMID: 38463398 PMC: 10924642. DOI: 10.1002/mco2.483.

PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma.

Huang C, Hsieh M, Yadav V, Wu Y, Liu S, Yeh C Int J Mol Sci. 2023; 24(24).

PMID: 38139175 PMC: 10744311. DOI: 10.3390/ijms242417346.

Reaction Mechanism of Human PAICS Elucidated by Quantum Chemical Calculations.

Prejano M, Skerlova J, Stenmark P, Himo F J Am Chem Soc. 2022; 144(31):14258-14268.

PMID: 35914774 PMC: 9376930. DOI: 10.1021/jacs.2c05072.

Multienzyme interactions of the de novo purine biosynthetic protein PAICS facilitate purinosome formation and metabolic channeling.

He J, Zou L, Pareek V, Benkovic S J Biol Chem. 2022; 298(5):101853.

PMID: 35331738 PMC: 9035706. DOI: 10.1016/j.jbc.2022.101853.

Evidence Supporting Substrate Channeling between Domains of Human PAICS: A Time-Course Analysis of C-Bicarbonate Incorporation.

Shon H, Matveeva E, Jull E, Hu Y, Coupet T, Lee Y Biochemistry. 2022; 61(7):575-582.

PMID: 35285625 PMC: 8988938. DOI: 10.1021/acs.biochem.1c00803.

References

Meng M, Chen Y, Jia J, Li L, Yang S . Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines. Biol Res. 2018; 51(1):24. PMC: 6086025. DOI: 10.1186/s40659-018-0172-9. View

Constantine C, Starks C, Mill C, Ransome A, Karpowicz S, Francois J . Biochemical and structural studies of N5-carboxyaminoimidazole ribonucleotide mutase from the acidophilic bacterium Acetobacter aceti. Biochemistry. 2006; 45(27):8193-208. DOI: 10.1021/bi060465n. View

Eshtad S, Mavajian Z, Rudd S, Visnes T, Bostrom J, Altun M . hMYH and hMTH1 cooperate for survival in mismatch repair defective T-cell acute lymphoblastic leukemia. Oncogenesis. 2016; 5(12):e275. PMC: 5177770. DOI: 10.1038/oncsis.2016.72. View

Groziak M, Bhat B, LEONARD N . Nonenzymatic synthesis of 5-aminoimidazole ribonucleoside and recognition of its facile rearrangement. Proc Natl Acad Sci U S A. 1988; 85(19):7174-6. PMC: 282146. DOI: 10.1073/pnas.85.19.7174. View

Cifola I, Pietrelli A, Consolandi C, Severgnini M, Mangano E, Russo V . Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling. PLoS One. 2013; 8(5):e63597. PMC: 3660556. DOI: 10.1371/journal.pone.0063597. View

Serao N, Delfino K, Southey B, Beever J, Rodriguez-Zas S . Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med Genomics. 2011; 4:49. PMC: 3127972. DOI: 10.1186/1755-8794-4-49. View

Tranchimand S, Starks C, Mathews I, Hockings S, Kappock T . Treponema denticola PurE Is a bacterial AIR carboxylase. Biochemistry. 2011; 50(21):4623-37. DOI: 10.1021/bi102033a. View

Agarwal S, Chakravarthi B, Kim H, Gupta N, Hale K, Balasubramanya S . PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression. Transl Oncol. 2020; 13(7):100776. PMC: 7229293. DOI: 10.1016/j.tranon.2020.100776. View

Brunger A . Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 1992; 355(6359):472-5. DOI: 10.1038/355472a0. View

10.

Liebschner D, Afonine P, Moriarty N, Poon B, Sobolev O, Terwilliger T . Polder maps: improving OMIT maps by excluding bulk solvent. Acta Crystallogr D Struct Biol. 2017; 73(Pt 2):148-157. PMC: 5297918. DOI: 10.1107/S2059798316018210. View

11.

Firestine S, Davisson V . Carboxylases in de novo purine biosynthesis. Characterization of the Gallus gallus bifunctional enzyme. Biochemistry. 1994; 33(39):11917-26. DOI: 10.1021/bi00205a030. View

12.

Gallenne T, Ross K, Visser N, Salony , Desmet C, Wittner B . Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer. Oncotarget. 2017; 8(13):20572-20587. PMC: 5400527. DOI: 10.18632/oncotarget.16244. View

13.

Firestine S, Poon S, Mueller E, Stubbe J, Davisson V . Reactions catalyzed by 5-aminoimidazole ribonucleotide carboxylases from Escherichia coli and Gallus gallus: a case for divergent catalytic mechanisms. Biochemistry. 1994; 33(39):11927-34. DOI: 10.1021/bi00205a031. View

14.

Mueller E, Meyer E, Rudolph J, Davisson V, Stubbe J . N5-carboxyaminoimidazole ribonucleotide: evidence for a new intermediate and two new enzymatic activities in the de novo purine biosynthetic pathway of Escherichia coli. Biochemistry. 1994; 33(8):2269-78. DOI: 10.1021/bi00174a038. View

15.

Goswami M, Chen G, Chakravarthi B, Pathi S, Anand S, Carskadon S . Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer. Oncotarget. 2015; 6(27):23445-61. PMC: 4695129. DOI: 10.18632/oncotarget.4352. View

16.

. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994; 50(Pt 5):760-3. DOI: 10.1107/S0907444994003112. View

17.

Hoskins A, Morar M, Kappock T, Mathews I, Zaugg J, Barder T . N5-CAIR mutase: role of a CO2 binding site and substrate movement in catalysis. Biochemistry. 2007; 46(10):2842-55. PMC: 2569195. DOI: 10.1021/bi602436g. View

18.

HARTMAN S, Buchanan J . Biosynthesis of the purines. XXVI. The identification of the formyl donors of the transformylation reactions. J Biol Chem. 1959; 234(7):1812-6. View

19.

LUKENS L, Buchanan J . Biosynthesis of the purines. XXIV. The enzymatic synthesis of 5-amino-1-ribosyl-4-imidazolecarboxylic acid 5'-phosphate from 5-amino-1-ribosylimidazole 5'-phosphate and carbon dioxide. J Biol Chem. 1959; 234(7):1799-805. View

20.

Manjunath K, Jeyakanthan J, Sekar K . Catalytic pathway, substrate binding and stability in SAICAR synthetase: A structure and molecular dynamics study. J Struct Biol. 2015; 191(1):22-31. DOI: 10.1016/j.jsb.2015.06.006. View